Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

PH III Immunotherapy alone or Comb. w/Chemo Induction/Maintenance or Postprogression Advncd NSCLC

Protocol: ECOG-ACRIN-EA5163

Full Title

A Randomized, Phase III Study of Firstline Immunotherapy alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature-driven Analysis

Lung Cancers